Accelsiors continues to support ADPD, with our attendance at this year’s conference in Lisbon, in March 2024!
ADPD 2024, brought together esteemed colleagues, investigators, and partners from around the world. The conference provided a platform for experts to showcase groundbreaking research, discuss recent challenges, and explore innovative solutions in the fields of Alzheimer’s and Parkinson’s diseases.
This year, attendees from all over the world had the chance to meet our colleague Thani Pavlidou, Business Development Director, and our partner from Aristotle University of Thessaloniki, Konstantinos Xanthopoulos at our poster. We presented the results of our study, demonstrating how the identification of a suitable panel of cerebrospinal fluid (CSF) biomarkers increases the potential to differentiate between patients with Alzheimer’s disease (AD), those with frontotemporal dementia (FTD), and healthy individuals. The implications of this study are far-reaching, offering hope to millions of individuals affected by these debilitating neurodegenerative disorders.
Beyond the scientific presentations, ADPD 2024 provided a unique opportunity for networking and knowledge sharing. Engaging discussions among experts from diverse backgrounds fostered a collaborative spirit, igniting new ideas and approaches to tackle the challenges faced in the field of neurology. We’re happy we got the chance to present our in-house-built systems. These state-of-the-art systems have enabled us to gather invaluable data, providing deeper insights into the complexities of Alzheimer’s and Parkinson’s diseases. By harnessing the power of technology and innovation, we have unlocked new avenues for exploration and paved the way for more effective clinical trial execution.
With a shared vision of improving the lives of those affected by neurodegenerative disorders, the global neurology community eagerly anticipates the next edition of ADPD. Until ADPD2025, we’re committed to making more breakthroughs and improving the lives of those affected by neurological disorders!
